Therapeutic PEG solution concentrate

Details for Australian Patent Application No. 2004290580 (hide)

Owner Braintree Laboratories, Inc.

Inventors Gay, Stanley Edward; Aaronson, Bruce Howard

Agent Davies Collison Cave

Pub. Number AU-A-2004290580

PCT Pub. Number WO2005/049049

Priority 60/523,200 17.11.03 US

Filing date 17 November 2004

Wipo publication date 2 June 2005

International Classifications

A61K 33/00 (2006.01) Medicinal preparations containing inorganic active ingredients

A61K 31/765 (2006.01)

A61K 33/06 (2006.01) Medicinal preparations containing inorganic active ingredients - Aluminium, calcium or magnesium

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/049049 Priority application(s): WO2005/049049

9 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004290581-Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters

2004290578-Determining stimulation levels for transcranial magnetic stimulation